Guaifenesin, pseudoephedrine hydrochloride
Mucus Relief D is an over-the-counter extended-release tablet containing guaifenesin (an expectorant that helps loosen mucus) and pseudoephedrine hydrochloride (a decongestant that relieves nasal and sinus congestion). Available in strengths like 600mg guaifenesin with 60mg pseudoephedrine or 1.2g guaifenesin with 120mg pseudoephedrine, it's taken orally to ease cold or allergy symptoms. Manufactured by Walgreen Company. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Mucus Relief D is an over-the-counter extended-release tablet containing guaifenesin (an expectorant that helps loosen mucus) and pseudoephedrine hydrochloride (a decongestant that relieves nasal and sinus congestion). Available in strengths like 600mg guaifenesin with 60mg pseudoephedrine or 1.2g guaifenesin with 120mg pseudoephedrine, it's taken orally to ease cold or allergy symptoms. Manufactured by Walgreen Company. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Guaifenesin, pseudoephedrine hydrochloride", "mediaType": "text/html", "description": " Access the FDA dataset for Guaifenesin, pseudoephedrine hydrochloride — ANDA 214407 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214407" } ] |
| identifier | ANDA214407 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "drug-manufacturers", "pharmaceuticals", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Guaifenesin, pseudoephedrine hydrochloride |
